Innovative MedTech, Inc. (IMTH)
OTCMKTS
· Delayed Price · Currency is USD
0.5800
+0.1500 (34.88%)
At close: Apr 14, 2025
Innovative MedTech Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 1.82 | 1.82 | 1.72 | 1.3 | 0.35 | - | Upgrade
|
| Revenue Growth (YoY) | 98.29% | 5.80% | 32.92% | 271.66% | - | - | Upgrade
|
| Cost of Revenue | 1.03 | 1.03 | 4.08 | 1.67 | 0.2 | 0.14 | Upgrade
|
| Gross Profit | 0.79 | 0.79 | -2.35 | -0.37 | 0.15 | -0.14 | Upgrade
|
| Selling, General & Admin | 5.02 | 3.34 | 1.27 | 17.88 | 0.86 | 0.23 | Upgrade
|
| Operating Expenses | 6.85 | 5.07 | 1.27 | 17.88 | 0.86 | 0.23 | Upgrade
|
| Operating Income | -6.05 | -4.27 | -3.62 | -18.26 | -0.71 | -0.38 | Upgrade
|
| Interest Expense | -0.2 | -0.2 | -0.22 | -0.19 | -0.17 | -0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.09 | 0.08 | 0.2 | 0.21 | -0.09 | 0.1 | Upgrade
|
| EBT Excluding Unusual Items | -6.16 | -4.39 | -3.65 | -18.24 | -0.97 | -0.49 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | -0.81 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.23 | -0.23 | - | - | 0 | - | Upgrade
|
| Asset Writedown | -3.3 | -3.3 | - | -0.08 | - | - | Upgrade
|
| Other Unusual Items | -0.01 | -0.01 | - | 0.27 | -1.49 | - | Upgrade
|
| Pretax Income | -9.7 | -7.94 | -3.65 | -18.06 | -3.26 | -0.49 | Upgrade
|
| Earnings From Continuing Operations | -9.7 | -7.94 | -3.65 | -18.06 | -3.26 | -0.49 | Upgrade
|
| Earnings From Discontinued Operations | 0.11 | - | - | - | - | - | Upgrade
|
| Net Income | -9.59 | -7.94 | -3.65 | -18.06 | -3.26 | -0.49 | Upgrade
|
| Net Income to Common | -9.59 | -7.94 | -3.65 | -18.06 | -3.26 | -0.49 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 24 | 21 | 17 | 2 | 0 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 24 | 21 | 17 | 2 | 0 | Upgrade
|
| Shares Change (YoY) | 28.52% | 12.80% | 27.43% | 684.26% | 624.52% | - | Upgrade
|
| EPS (Basic) | -0.35 | -0.33 | -0.17 | -1.09 | -1.54 | -1.68 | Upgrade
|
| EPS (Diluted) | -0.35 | -0.33 | -0.17 | -1.09 | -1.54 | -1.68 | Upgrade
|
| Free Cash Flow | -0.2 | -0.23 | -0.18 | -0.63 | 0.03 | -0.05 | Upgrade
|
| Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.04 | 0.01 | -0.17 | Upgrade
|
| Gross Margin | 43.51% | 43.51% | -136.38% | -28.78% | 43.32% | - | Upgrade
|
| Operating Margin | -331.77% | -234.21% | -210.12% | -1407.05% | -203.03% | - | Upgrade
|
| Profit Margin | -525.70% | -435.03% | -211.49% | -1391.66% | -935.13% | - | Upgrade
|
| Free Cash Flow Margin | -11.11% | -12.81% | -10.53% | -48.49% | 8.05% | - | Upgrade
|
| EBITDA | -6.02 | -4.22 | -3.58 | -18.19 | -0.7 | - | Upgrade
|
| EBITDA Margin | - | -231.49% | -207.31% | - | -200.27% | - | Upgrade
|
| D&A For EBITDA | 0.03 | 0.05 | 0.05 | 0.07 | 0.01 | - | Upgrade
|
| EBIT | -6.05 | -4.27 | -3.62 | -18.26 | -0.71 | -0.38 | Upgrade
|
| EBIT Margin | - | -234.21% | -210.12% | - | -203.03% | - | Upgrade
|
| Revenue as Reported | 1.82 | 1.82 | 1.72 | 1.3 | 0.35 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.